Ascentage Pharma GR-ADRAAPG
13F holders, Q3 2025 (September 30)14holders +2
6new positions
4sold out
1famous investor
$39.18avg. 13F price*
At the end of Q3 2025, 14 institutions reported holding Ascentage Pharma GR-ADR (AAPG) in their 13F filings, up 2 from Q2 2025. 6 opened new positions and 4 sold out. The largest holders were UBS Group AG ($716K), XY Capital Ltd ($707K) and Point72 (DIFC) Ltd ($700K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Ascentage Pharma GR-ADR
- CUSIP
- 04390B105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $731K |
| Exits | 4 | $626K |
All 13F filers, Q2 2025 → Q3 2025: 42,135 shares bought and 29,836 shares sold, net +12,299 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| UBS Group AG | 0.00% | Add +149.3% | 18,345 | $716K |
| XY Capital Ltd | 0.59% | Add +224.2% | 18,120 | $707K |
| Point72 (DIFC) Ltd | 0.05% | Reduce -14.2% | 17,930 | $700K |
| NEOS Investment Management LLC | 0.00% | Reduce -33.0% | 10,385 | $412K |
| Tema ETFs LLC | 0.03% | Reduce -33.0% | 10,385 | $405K |
| Citadel Advisors | 0.00% | New | 9,652 | $383K |
| Abc Arbitrage SA | 0.02% | New | 5,230 | $204K |
| Mirae Asset Global Investments Co., Ltd. | 0.00% | New | 2,463 | $96K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 829 | $32K |
| Osaic Holdings, Inc. | 0.00% | New | 220 | $8K |
| Morgan Stanley | 0.00% | Reduce -78.8% | 203 | $8K |
| Bank of America Corp. | 0.00% | New | 180 | $7K |
| Bell Investment Advisors, Inc | 0.00% | No change | 67 | $3K |
| EverSource Wealth Advisors, LLC | 0.00% | Add +179.2% | 67 | $3K |
"% of holder's portfolio" is AAPG's weight in each manager's 13F, not the share of Ascentage Pharma GR-ADR the manager owns.